SUSAN WOODWARD: Open Payments
NPI 1366740581 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,954 in 12 payments from 9 companies in 2025. Trend: 2023 $3,547 · 2024 $1,270 · 2025 $1,954
Food & beverage: $1,174Consulting: $780
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 2 | $862 |
| Lilly USA, LLC | 2 | $226 |
| ABBVIE INC. | 2 | $225 |
| Syndax Pharmaceuticals, Inc. | 1 | $149 |
| Celgene Corporation | 1 | $131 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 1 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $65 |
| Acrotech Biopharma Inc. | 1 | $64 |
Products named: EPKINLY, BREYANZI, JAYPIRCA, CALQUENCE, SCEMBLIX, BELEODAQ.
Industry payments across FL — which companies pay providers there.
